Search
for
Sort by
Research 361–390 of 775
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- EFFECTS OF LIRAGLUTIDE ON VISCERAL ADIPOSITY INDEX IN WOMAN OF REPRODUCTIVE AGE WITH PREDIABETES
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- P718 Observational real-world evidence on the efficacy and safety of Janus Kinase inhibitors (JAKi) in the treatment of moderate to severe Active Ulcerative Colitis (UC)
- AUTOLOGOUS FAT GRAFTING UPDATE. PRESENTATION OF OWN RESULTS IN FACIAL REGENERATION
- THE USE OF AN IMMUNOMODULATOR WITH AN ANTISEPTIC IN THE TREATMENT OF INFECTED AND PURULENT WOUNDS IN AN EXPERIMENT
- Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment
- Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata
- Hair Loss in Lichen Planopilaris and Frontal Fibrosing Alopecia: Not Always Irreversible
- Effective treatment of alopecia universalis with oral tofacitinib: A case report
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Functional complexity of hair follicle stem cell niche and therapeutic targeting of niche dysfunction for hair regeneration
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Conventional and novel stem cell based therapies for androgenic alopecia
- New therapies for alopecia areata
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Frontal fibrosing alopecia: An update on the hypothesis of pathogenesis and treatment
- Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis
- Ruxolitinib found to cause eyelash growth: a case report
- 53274 Real-world experience of efficacy and safety of baricitinib in Korean patients with severe alopecia areata
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- Off-Label Treatment of Alopecia Areata—Retrospective Study
- Interleukin-15 and Tumor Necrosis Factor-α in Iraqi Patients with Alopecia Areata
- Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
- Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Baricitinib maintains regrowth of hair, eyebrows, and eyelashes over 3 years
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes